Table 3. HSCT after treatment dose .... | American Society of Hematology

Table 3.

HSCT after treatment dose

	Time from gemtuzumab ozogamicin exposure to HSCT, d
Patients with HSCT	First dose	Second dose	VOD
1	110	84	Yes
2	140	121	—
3	50	*	—
4	50	35	—
5	71	55	—
6	95	*	—
7	64	48	Yes
8	424	410	—
9	86	72	Yes
10	120	106	Yes
11	67	53	—
12	59	45	Yes
13	118	104	—
14	56	42	—
15	20	*	Yes

	Time from gemtuzumab ozogamicin exposure to HSCT, d
Patients with HSCT	First dose	Second dose	VOD
1	110	84	Yes
2	140	121	—
3	50	*	—
4	50	35	—
5	71	55	—
6	95	*	—
7	64	48	Yes
8	424	410	—
9	86	72	Yes
10	120	106	Yes
11	67	53	—
12	59	45	Yes
13	118	104	—
14	56	42	—
15	20	*	Yes

— indicates no VOD.

Did not receive a second dose of gemtuzumab ozogamicin.